Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma

Bioorganic & Medicinal Chemistry Letters
1998.0

Abstract

The synthesis and pharmacological profile of a novel series of potent and selective phosphodiesterase type IV (PDE IV) inhibitors is described.

Knowledge Graph

Similar Paper

Synthesis and evaluation of a novel series of phosphodiesterase IV inhibitors. A potential treatment for asthma
Bioorganic & Medicinal Chemistry Letters 1998.0
7-Methoxybenzofuran-4-carboxamides as PDE 4 inhibitors: a potential treatment for asthma
Bioorganic & Medicinal Chemistry Letters 2000.0
7-Methoxyfuro[2,3-c]pyridine-4-carboxamides as PDE4 Inhibitors: A Potential Treatment for Asthma
Bioorganic & Medicinal Chemistry Letters 2002.0
Selective Type IV Phosphodiesterase Inhibitors as Antiasthmatic Agents. The Syntheses and Biological Activities of 3-(Cyclopentyloxy)-4-methoxybenzamides and Analogs
Journal of Medicinal Chemistry 1994.0
Synthesis and Biological Activity of Pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidines as Phosphodiesterase Type 4 Inhibitors
Journal of Medicinal Chemistry 2010.0
The synthesis and biological evaluation of a novel series of phthalazine PDE4 inhibitors I
Bioorganic & Medicinal Chemistry Letters 2000.0
Palladium-Catalyzed Cross-Coupling Reactions for the Synthesis of 6,8-Disubstituted 1,7-Naphthyridines:  A Novel Class of Potent and Selective Phosphodiesterase Type 4D Inhibitors
Journal of Medicinal Chemistry 2000.0
Quaternary substituted PDE4 inhibitors I: The synthesis and in vitro evaluation of a novel series of oxindoles
Bioorganic & Medicinal Chemistry Letters 1998.0
Synthesis and in vitro profile of a novel series of catechol benzimidazoles. The discovery of potent, selective phosphodiesterase type IV inhibitors with greatly attenuated affinity for the [3H]rolipram binding site
Bioorganic & Medicinal Chemistry Letters 1995.0
Phthalazine PDE4 inhibitors. Part 3: The synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor
Bioorganic & Medicinal Chemistry Letters 2002.0